28.10.2026Franziska Niemeyer Learned to Profile Cells in Their Spatial Context – Now She’s Teaching Others
1.10.2026How a Tooth Reveals a Vanished Life: Ancient DNA Tells Stories from the Past That Would Otherwise Stay Hidden
12.8.2026The Same Genetic Variant, Different Diseases – Mitochondrial Research Seeks Answers
17.6.2026Fungal viruses and a 100-million-piece jigsaw puzzle
20.5.2026A cell researcher's new tools
10.4.2026The Mystery of Brain Development
27.2.2026Modelling helps to identify a rare childhood neurological disorder caused by missense mutations of SynGAP1 protein
23.6.2025Too clean is unhealthy
8.5.2025Alkaloids derived from tree bark destroy cancer cells
27.3.2025Vinca alkaloids: Madagascar’s gift to cancer treatment
6.2.2025Genetic testing improves medication safety and effectiveness
26.12.2024The ComPatAI consortium uses large datasets to create an AI learning model for pathology
14.11.2024Microbiota affects the immune system
21.10.2024The skin’s wide range of microbiota improves the immune system
30.9.2024New drug targets from RNA-binding proteins
31.8.2024New machine learning method speeds up drug screening hundred-fold
22.7.2024Mapping the coffee genome to improve disease resistance
25.6.2024Why do some get the severe form of COVID-19?
30.5.2024An AI model that understands health data warns of future diseases
29.4.2024An infrastructure for genomic data
1.4.2024European research community preparing for next pandemic
8.3.2024Evolutionary dynamics of viruses and other microbes affect human health
2.3.2024A million European genomes
20.2.2024Efficient transfer and analysis of biological image data through web interfaces
23.1.2024Improving breast cancer treatment prognoses with liquid biopsy
15.12.2023The European Health Data Space: health data moves across borders for research purposes
16.11.2023New method for measuring gut microbiota
31.10.2023Purifying mining wastewater with plant-associated microbes
29.9.2023Artificial intelligence helps researchers find suitable drugs based on patient’s genetic data and cancer cell samples
1.9.2023Combining data from different sources for personalised treatment
15.8.2023Better treatments for leukaemia
10.6.2023MicroRNAs may reveal type 1 diabetes
16.5.2023Single-cell RNA sequencing enabling individual disease treatment
12.4.2023Tissue samples analysed with Sensitive Data (SD) services provide new information on celiac disease and other autoimmune diseases
20.3.2023DNA isolated from Baltic Sea sediment shedding light on climate change and biodiversity
27.2.2023Organoids grown from stem cells boost cancer research
19.12.2022Sensitive Data (SD) services for Research: with a few clicks a researcher can launch a personal secure computing environment
30.11.2022Microbiota in permafrost play an important role in climate change
20.10.2022Reusable, accurately described and high-quality data – tools created by the research community for agile data management
29.9.2022Gene sequencing used for study of structure and functioning of microbial communities in oceans
1.9.2022Antibiotic-resistant bacteria are a global problem
23.8.2022Personalised medicine against cancer and viruses
30.6.2022Studying the human microbiome is a key towards holistic understanding of our health
23.5.2022FINRISK: one of the world’s longest-running population survey time series
8.4.2022Combining biobank data with data from health registers enables research towards personalised treatment
3.3.2022Finnish research team sequences the genomes of thousands of individuals with diabetes to look for genetic risk factors
10.2.2022BIGPICTURE helps pathology go digital
30.12.2021Sensitive data infrastructure
23.11.2021In the future, an algorithm may diagnose glaucoma from fundus photos
26.10.2021Patient data creating better artificial intelligence models
15.9.2021Teaching an algorithm to identify cancer from sequence data
3.12.2020Efficient processing and sharing of data improving disease diagnosis and treatment
10.11.2020Bioinformatics to revolutionise healthcare: Efficient data processing speeds up diagnoses and enables personalised drug treatments
27.8.2020Tissue samples into digital images, interpreted by artificial intelligence
9.6.2020Digital pathology speeds up diagnosis
18.5.2020Searching markers for breast cancer by machine learning
8.4.2020Metabolomics measures and analyses metabolic changes caused by illness, diet or medication
1.3.2020Deep learning algorithms help in breast cancer screening
13.2.2020All breast cancer risk factors evaluated with AI
6.2.2020A dog can smell diseases
2.12.2019ELIXIR Compute Platform for life and health sciences
18.11.2019New bioinformatics methods and measurement technologies call for continuously updated courses and analysis software
30.10.2019No need to turn up personally: SisuID improves electronic authentication
30.9.2019Risk assessment of cardiovascular diseases for all citizens
20.8.2019Federated user ID management: a single identity giving access to numerous bioinformatics services
4.9.2019Targeted treatment for venous diseases with vascular system modelling
4.7.2019Research on rare genetic disorders can be utilised in understanding the mechanisms behind even more common diseases
3.6.2019VEIL.AI: patient data in a veil
20.5.2019Biocenter Oulu: technology services for biomedical research
23.4.2019Mouse models provide insights into the causal mechanisms of diseases
4.3.2019Euro-BioImaging: imaging infrastructure
26.2.2019Imaging helps to highlight significance of data
14.1.2019Data harmony and standards: data must be processed, described and stored by uniform means
10.12.2018Hundreds of genes could lie behind a single disease
5.11.2018Help from the Finnish genome for the prevention of cardiovascular diseases
8.10.2018Disease prediction models are becoming more accurate thanks to the computational methods
11.9.2018Genetic data under control and in the desired format
23.8.2018Massive data management project: Finns’ heredity is collected and safeguarded
14.6.2018Half of all drug ingredients affect only three protein families
12.6.2018Looking for a good drug
29.5.2018Quick DNA analysis of patient samples with artificial intelligence
7.5.2018Secrets of the intestines
4.4.2018Algorithm determines the appropriate drug
19.3.2018Bank of million patient samples
20.2.2018Mapping the genomes of all organisms enables the development of new vaccines and medicines
7.2.2018Ordered and secured
2.11.2017Striving for a national service to utilise genomic data in health care
11.8.2017Better harvests on the horizon? Data will also be harvested
19.6.2017Microbes and climate change
21.5.2017Storing the whole genome of the Finnish population? The data will benefit disease research
6.4.2017”Smart life insurances” offered: human biological data is only useful when interpreted correctly
15.1.2016New drug molecules through determining the structure of proteins
26.10.2015BBMRI.fi: an IT Infrastructure for shared biobanks
24.9.2015Fighting cancer with mathematics
10.8.2015Saimaa ringed seal aids the study of population genomes
1.8.2015Webmicroscope stores tissue samples in the cloud
15.7.2015Pups and Pooches Behind Genetic Discoveries in Human Diseases Canine Genetic Research Benefits from ELIXIR Databases
5.6.2015Life sciences in European cloud

Visium HD dataset of a human ovarian cancer sample. The capture area measures 6.5 × 6.5 mm, containing approximately 11.2 million continuous capture spots. Dataset is publicly available from 10x Genomics; image edited by Franziska Niemeyer.
Spatial transcriptomics is such a new technique that it doesn’t even have established standards for analysis yet. University of Helsinki researcher Franziska Niemeyer learned the method on an international top-level course – and this spring brought it within reach of Finnish researchers too.
What is a cell up to? There are many ways to approach that question, but one of the most effective is to sequence the cell’s RNA. RNA shows which genes are active in the cell. From this, you can further deduce whether a cell belongs to, say, a tumour, or is healthy tissue.
The traditional way of doing sequencing has been to take a tissue sample and analyse it as one lump. A single sample, however, can contain millions of cells, and the final analysis ends up telling you more about what the sample’s cells did on average than about the activity of individual cells.
This kind of analysis could be compared to studying a Lego model by taking it apart and calculating averages of the pieces’ shapes, sizes and colours. This level of precision may be enough if, say, you just want to see whether a lump under the skin is a tumour – but sometimes more precise methods are needed.
A more sophisticated alternative is so-called single-cell analysis. To continue the Lego analogy: the model is taken apart further, but this time the pieces are sorted by type into some kind of order. This lets you focus on examining an individual piece. This kind of analysis, however, loses the bigger picture: even though a piece is red and has six studs, we no longer know where in the structure it was located.
When looking at cells, this is a problem, because the cells in the body don’t operate in a vacuum but interact with other cells. So, focusing on just one cell, without its relationship to neighbouring cells, never gives the full picture of what a cell is doing. Better techniques were needed.

In 2018, Franziska Niemeyer began studying bioinformatics and genome research at Bielefeld University in Germany. Already at the start of her studies, she was interested in computer vision and image analysis – computers could analyse visual data more precisely and reliably than the human eye.
In 2022, during her master’s studies in Helsinki, Niemeyer was looking for a research group where she could pursue a PhD. She found Andrew Erickson’s newly established research group, which focused on prostate cancer and used a new and interesting technique: spatial transcriptomics. Niemeyer was eager to join the group.
It really was a brand-new technique. The key scientific breakthroughs behind spatial transcriptomics had only been made in 2016, and the first commercial applications came in 2019 – that is, after Niemeyer had already started her studies.
”The new technique seemed interesting right away. I wanted to learn more about it”, Niemeyer says.
The original sequence-based spatial transcriptomics is an analysis technique in which a tissue sample is placed on a special kind of microscopy slide with probes attached to it that can capture RNA molecules. It can be imagined as a piece of blotting paper onto which the tissue sample is placed and where RNA molecules released from the tissue are captured. At the same time, a high-resolution image of the tissue is taken. The output is essentially a map: for each position on the microscopy image of the tissue, you know which genes are active. The resolution of the technique varies, ranging from approximately 20 cells per capture location to subcellular resolution.
The technique has two challenges, however. First, it is new and therefore expensive: a single experiment with four 6.5 × 6.5-millimetre capture areas costs almost 15,000 euros.
Second, the technique produces enormous amounts of data. Even though a piece of paper a few millimetres across doesn’t sound like much, a single 6.5 × 6.5-millimetre sample capture area can hold as many as hundreds of thousands of cells. With hundreds of thousands of RNA molecules in each of them, each typically 1,000–2,000 bases long, the amount of data contained in a single sample climbs to levels that are too much for ordinary computers. There is also no established analysis workflow for processing this type of data yet.
”Getting to grips with analysing spatial transcriptomics data basically means learning to code your analysis”, Niemeyer explains.
The challenge didn’t scare Niemeyer off. In 2025, together with 30 other researchers, she attended a four-day spatial transcriptomics course organised by the ELIXIR Single-Cell Omics Community in Lausanne, Switzerland.
The course had lectures and analysis exercises. In these sessions, students used different types of analysis codes. Because the technology is still so new and every experiment is different, the code must be tailored separately for each experiment, in order to filter out what’s essential from the huge volume of data.
”The course was very inspiring and well organised. It was interesting to chat with some of the biggest names in the field over lunch”, Niemeyer recalls.
Still, the biggest surprise in the end was how unstructured the field still is.
”When you asked about standards in the field – for quality control, sample normalisation, or cell segmentation, for instance – you’d often get the answer that even the experts didn’t really know yet which method is the best.”

After the course, Niemeyer returned to Finland and began putting what she had learned to use in her doctoral research. It deals with the evolution of prostate cancer tumours and the development of non-invasive diagnostic tools.
”Lately my research has also turned toward developing open-source, automated workflows for spatial assays”, Niemeyer says.
She also decided to pass on what she had learned. In 2026, Niemeyer co-organised a spatial transcriptomics course at the University of Helsinki. Overall responsibility for the course lay with Associate Professor Anna Vähärautio, but Niemeyer handled the practical organisation and led part of the hands-on exercises.
The two-week course drew partly on materials from Lausanne.
”All the Lausanne lectures were recorded, so we could make them available for our course participants as well.”
Invaluable help also came from Noppe, the teaching platform run by CSC – IT Center for Science, where course participants could simulate the kind of computing normally done on a supercomputer.
”Noppe worked excellently. At first, we also considered booking time on an actual supercomputer, but for purely teaching purposes that wouldn’t have made sense. In the end, though, we gave instructions for using Puhti and later Roihu to those who wanted to make use of the technique in their own research.”
The Helsinki course also took in 30 participants, but unlike in Lausanne – where students were deliberately selected from across Europe – the majority of the Helsinki participants came from the University of Helsinki itself.
The course organised by the University of Helsinki represents the strength of the ELIXIR network, says Eija Korpelainen, Training Coordinator for ELIXIR Finland. She was one of the founders of the ELIXIR Single-Cell Omics Community and has been involved in its work from the start, since 2022.
She was also involved in selecting the participants for the Lausanne course. The idea was to spread knowledge and expertise as widely as possible, so participants were recruited from all over Europe.
”Training is essential for turning this expensive data into valuable knowledge.”
As a new research method, spatial transcriptomics is also developing rapidly, with commercial players bringing new technologies to market.
“The development of both laboratory technologies and analysis methods is so rapid that international collaboration is needed to identify the best approaches. By working together, we can also offer advanced courses for researchers.”
Niemeyer says she would be happy to help other universities organise similar courses in Finland.
Interest in spatial transcriptomics is strong across Finland and Europe. The latest international spatial transcriptomics course organised by the ELIXIR Single-Cell Omics Community took place in Uppsala on 6 October 2026. Eight Finnish researchers from different universities were selected to participate.
A project by the ELIXIR Single-Cell Omics Community has been selected for ELIXIR BioHackathon Europe 2026. In this project, researchers will develop methods for integrating single-cell datasets from different repositories and species to enable comparisons of corresponding cell types across species.
Text: Juha Merimaa
Photos: Juha Merimaa and Franziska Niemeyer
28 October 2026